Cushing´s Disease Epidemiology in Sweden

Status Completed

Clinical Trial Summary

The purpose of this study is to study since 1987 all patients diagnosed with CD in Sweden and determine their outcomes including mortality. A secondary objective is to focus on patients in remission and identify determinants of their different outcomes.

Clinical Trial Description

This study is a retrospective nationwide study of all patients in Sweden with diagnosis CD between 1987 and 2013 were baseline data at diagnosis, information about the different treatments and follow-up data is going to be obtained by reviewing patients' medical journals. This information as well as the exact diagnose criteria for each patient are going to be extracted by Endocrinologists in all University Hospitals in Sweden. An expert group at the Sahlgrenska University Hospital in Gothenburg will put together the data.By the use of the Swedish Personal Number, the investigators are going to obtain information about both patients' and background population co-morbidities which have been collected in the different Swedish Registers.

Primary aim:

To study mortality of CD in Sweden.

Secondary aims:

1. To study the influence of CD on myocardial infarction

2. To study the influence of CD on stroke

3. To study the influence of CD on cancer

4. To study the influence of CD on hip fracture risk

5. To study incidence and prevalence of CD in Sweden. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02350153
Study type	Observational
Source	Vastra Gotaland Region
Contact
Status	Completed
Phase
Start date	September 2013
Completion date	April 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03297892` - Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015	N/A
Recruiting	`NCT05804669` - A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome	Phase 1/Phase 2
Recruiting	`NCT03364803` - Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Recruiting	`NCT03774446` - Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease	Phase 2
Completed	`NCT03080181` - Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment	Phase 4
Recruiting	`NCT03831958` - Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Completed	`NCT01331239` - Safety and Efficacy of LCI699 in Cushing's Disease Patients	Phase 2
Completed	`NCT04201444` - Hair Cortisol and Cushing's Disease	N/A
Completed	`NCT02233335` - The Factors Associated With the Recurrence in Patients With Cushing Disease	N/A
Recruiting	`NCT04374721` - Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders	N/A
Recruiting	`NCT03974789` - Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms
Completed	`NCT03621280` - Open-label Treatment in Cushing's Syndrome	Phase 3
Not yet recruiting	`NCT05971758` - Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease	Phase 2
Recruiting	`NCT04486859` - Postoperative Thrombosis Prevention in Patients With CD	N/A
Completed	`NCT00171951` - Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease	Phase 2
Recruiting	`NCT00001595` - An Investigation of Pituitary Tumors and Related Hypothalmic Disorders